Richards C Marc
Known title: EVP, Chief Financial OfficerCIK: 0001468881
Associated companies
Transaction History
| MD | ▼ Sell | Open Market | 17,438 | $176K | 8/12/2024 | View on chart |
| MD | ▼ Sell | Open Market | 32,562 | $328K | 8/9/2024 | View on chart |
| MD | ▲ Buy | Grant | 95,760 | $0 | 6/1/2024 | View on chart |
| MD | ▼ Sell | Tax Withholding | 21,428 | $196K | 3/1/2024 | View on chart |
| MD | ▼ Sell | Tax Withholding | 9,991 | $157K | 3/1/2023 | View on chart |
| MD | ▲ Buy | Grant | 45,308 | $0 | 3/1/2023 | View on chart |
| MD | ▲ Buy | Grant | 30,502 | $0 | 3/1/2022 | View on chart |
| MD | ▲ Buy | Grant | 30,501 | $0 | 3/1/2022 | View on chart |
| MD | ▼ Sell | Tax Withholding | 6,874 | $161K | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
MD mentioned in list of stocks with questionable fundamentals
Pediatrix Medical Group (MD) was recently included in a Yahoo Finance article highlighting three unpopular stocks with questionable fundamentals. This mention draws attention to the company's valuation and financial metrics, placing it in a category that some market observers view with caution. The stock currently trades near its 52-week high range, with an average analyst target price of $26.33.
MD mentioned in list of stocks with questionable fundamentals. Pediatrix Medical Group (MD) was recently included in a Yahoo Finance article highlighting three unpopular stocks with questionable fundamentals. This mention draws attention to the company's valuation and financial metrics, placing it in a category that some market observers view with caution. The stock currently trades near its 52-week high range, with an average analyst target price of $26.33.